FIBROBIOLOGICS
Based in Houston, Texas, FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. Currently, FibroBiologics holds 150+ U.S. and International issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
FIBROBIOLOGICS
Founded:
2021-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.fibrobiologics.com
Total Employee:
11+
Status:
Active
Contact:
(281) 461-6211
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Virion Therapeutics
Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virally-associated cancers.
Current Employees Featured
Founder
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Private Equity Round - FibroBiologics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | FibroBiologics Appoints Mark C. Andersen as Chief Financial Officer |
Official Site Inspections
http://www.fibrobiologics.com Semrush global rank: 9.71 M Semrush visits lastest month: 114
- Host name: 16.110.212.35.bc.googleusercontent.com
- IP address: 35.212.110.16
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "FibroBiologics"
FibroBiologics, Inc. (FBLG)
Nov 5, 2024 FibroBiologics represents the next generation of medical advancement in cell therapy. View Executive Team View Board of Directors. Latest Financial Results. Q3 2024. Quarter Ended Sep 30, 2024. Earnings …See details»
FibroBiologics - Crunchbase Company Profile & Funding
FibroBiologics is exploring fibroblast cell-based therapies to improve and extend the productive life of the thymus, which is crucial for T cell maturation and immune function. Spleen FibroBiologics is investigating the use of fibroblast …See details»
Pioneering Experts - FibroBiologics
FibroBiologics was founded 2 years ago to deliver on that promise and harness the potential power of fibroblast cell-based therapies for patients, everywhere. From research to medicine, …See details»
FIBROBIOLOGICS, INC.
FibroBiologics, Inc. (the “ ompany” or “FibroBiologics”) was originally formed as an LL under the laws of the State of Texas on April 8, 2021, and then converted to a Delaware corporation on …See details»
FibroBiologics Reports Third Quarter 2024 Financial Results and ...
HOUSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and …See details»
FibroBiologics (Nasdaq: FBLG) - LinkedIn
FibroBiologics (Nasdaq: FBLG) is the world leader in cell therapy using fibroblasts to regenerate tissue and cure chronic diseases. Currently, FibroBiologics holds 150+ U.S. and international ...See details»
FibroBiologics, Inc. (FBLG) Company Profile & Facts - Yahoo Finance
See the company profile for FibroBiologics, Inc. (FBLG) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
FibroBiologics, LLC - VentureRadar
Currently, FibroBiologics holds 150+ U.S. and international issued patents/patents pending across a variety of clinical pathways, including disc degeneration, orthopedics, multiple sclerosis and …See details»
FibroBiologics - Craft
Sep 18, 2024 FibroBiologics is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with …See details»
FibroBiologics - Updates, News, Events, Signals & Triggers
FibroBiologics, a clinical-stage biotechnology company, announced its 2024 annual meeting and reported a breakthrough in developing an artificial thymus organoid for immune restoration. …See details»
FibroBiologics Introduces Scientific Advisory Board
Dec 15, 2021 Preeminent scientists join FibroBiologics to provide input for the growing clinical pipeline of cell therapies HOUSTON, Dec. 15, 2021 /PRNewswire/ -- FibroBiologics, a clinical …See details»
Pete O'Heeron - FibroBiologics
O’Heeron is Chief Executive Officer of FibroBiologics and a seasoned leader in his field comprising over 25 years of experience in medical technology and biotech development. As …See details»
FibroBiologics Reports Third Quarter 2024 Financial Results and ...
Fibrobiologics, Inc. Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans ...See details»
FibroBiologics and Charles River Announce Collaboration to …
HOUSTON, Oct. 18, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading global drug …See details»
Robert Hoffman - FibroBiologics
Robert Hoffman Director / Interim Chief Financial Officer Mr. Hoffman became our Interim Chief Financial Officer in October 2024. He is a key member of the FibroBiologics executive …See details»
FibroBiologics Sets Record as Fastest Rising Biotech in History with ...
Feb 1, 2023 About FibroBiologics. Based in Houston, FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments for chronic diseases using …See details»
FibroBiologics Secures $100 Million Capital Commitment from …
HOUSTON, Nov. 16, 2021 /CNW/ -- FibroBiologics, a clinical stage company developing fibroblast-based therapeutic cures for chronic diseases, announced today that it has signed an …See details»
FibroBiologics Plans to Collaborate with Charles River to …
FibroBiologics Investor Relations: Nic Johnson Russo Partners (212) 845-4242 [email protected]. FibroBiologics Media Contact: Liz Phillips Russo Partners …See details»
Fibroblasts are more effective and potent than stem cells
Fibroblasts share many of the characteristics of stem cells, including differentiation and immune modulation. Our studies have proven fibroblasts to be more effective and more potent than …See details»